Morbidity and Mortality Weekly Report最新文献_第4页

Surveillance To Track Progress Toward Polio Eradication — Worldwide, 2022–2023 跟踪根除脊髓灰质炎进展情况的监测--全球，2022-2023 年

Morbidity and Mortality Weekly Report Pub Date : 2024-04-04 DOI: 10.15585/mmwr.mm7313a1

Nishant Kishore, Elizabeth Krow-Lucal, O. Diop, J. Jorba, Tigran Avagnan, Varja Grabovac, A. Kfutwah, T. Johnson, Sudhir Joshi, L. Sangal, S. Sharif, Ashraf Wahdan, G. Tallis, Stephanie D Kovacs

{"title":"Surveillance To Track Progress Toward Polio Eradication — Worldwide, 2022–2023","authors":"Nishant Kishore, Elizabeth Krow-Lucal, O. Diop, J. Jorba, Tigran Avagnan, Varja Grabovac, A. Kfutwah, T. Johnson, Sudhir Joshi, L. Sangal, S. Sharif, Ashraf Wahdan, G. Tallis, Stephanie D Kovacs","doi":"10.15585/mmwr.mm7313a1","DOIUrl":"https://doi.org/10.15585/mmwr.mm7313a1","url":null,"abstract":"The reliable and timely detection of poliovirus cases through surveillance for acute flaccid paralysis (AFP), supplemented by environmental surveillance of sewage samples, is a critical component of the polio eradication program. Since 1988, the number of polio cases caused by wild poliovirus (WPV) has declined by >99.9%, and eradication of WPV serotypes 2 and 3 has been certified; only serotype 1 (WPV1) continues to circulate, and transmission remains endemic in Afghanistan and Pakistan. This surveillance update evaluated indicators from AFP surveillance, environmental surveillance for polioviruses, and Global Polio Laboratory Network performance data provided by 28 priority countries for the program during 2022-2023. No WPV1 cases have been detected outside of Afghanistan and Pakistan since August 2022, when an importation into Malawi and Mozambique resulted in an outbreak during 2021-2022. During 2022-2023, among 28 priority countries, 20 (71.4%) met national AFP surveillance indicator targets, and the number of environmental surveillance sites increased. However, low national rates of reported AFP cases in priority countries in 2023 might have resulted from surveillance reporting lags; substantial national and subnational AFP surveillance gaps persist. Maintaining high-quality surveillance is critical to achieving the goal of global polio eradication. Monitoring surveillance indicators is important to identifying gaps and guiding surveillance-strengthening activities, particularly in countries at high risk for poliovirus circulation.","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"30 21","pages":"278 - 285"},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140744743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Notice to Readers: Change in Publication Date of QuickStats 读者须知：快速统计》出版日期变更

Morbidity and Mortality Weekly Report Pub Date : 2024-04-04 DOI: 10.15585/mmwr.mm7313a3

引用次数: 0

Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics — United States, September 1, 2022–September 30, 2023 2022 年 9 月 1 日至 2023 年 9 月 30 日美国不同社会人口特征的联邦零售药房计划对二价 mRNA COVID-19 疫苗接种的贡献率

Morbidity and Mortality Weekly Report Pub Date : 2024-04-04 DOI: 10.15585/mmwr.mm7313a2

Roua El Kalach, Nkenge H. Jones-Jack, Mattie A Elam, A. Olorukooba, Marley Vazquez, Shannon Stokley, Sarah Meyer, S. McGarvey, Kimvy Nguyen, L. G. Scharf, Latreace Harris, Christopher Duggar, Lori B Moore

{"title":"Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics — United States, September 1, 2022–September 30, 2023","authors":"Roua El Kalach, Nkenge H. Jones-Jack, Mattie A Elam, A. Olorukooba, Marley Vazquez, Shannon Stokley, Sarah Meyer, S. McGarvey, Kimvy Nguyen, L. G. Scharf, Latreace Harris, Christopher Duggar, Lori B Moore","doi":"10.15585/mmwr.mm7313a2","DOIUrl":"https://doi.org/10.15585/mmwr.mm7313a2","url":null,"abstract":"The Federal Retail Pharmacy Program (FRPP) facilitated integration of pharmacies as partners in national efforts to scale up vaccination capacity during the COVID-19 pandemic emergency response. To evaluate FRPP's contribution to vaccination efforts across various sociodemographic groups, data on COVID-19 bivalent mRNA vaccine doses administered during September 1, 2022-September 30, 2023, were evaluated from two sources: 1) FRPP data reported directly to CDC and 2) jurisdictional immunization information systems data reported to CDC from all 50 states, the District of Columbia, U.S. territories, and freely associated states. Among 59.8 million COVID-19 bivalent vaccine doses administered in the United States during this period, 40.5 million (67.7%) were administered by FRPP partners. The proportion of COVID-19 bivalent doses administered by FRPP partners ranged from 5.9% among children aged 6 months-4 years to 70.6% among adults aged 18-49 years. Among some racial and ethnic minority groups (e.g., Hispanic or Latino, non-Hispanic Black or African American, non-Hispanic Native Hawaiian or other Pacific Islander, and non-Hispanic Asian persons), ≥45% of COVID-19 bivalent vaccine doses were administered by FRPP partners. Further, in urban and rural areas, FRPP partners administered 81.6% and 60.0% of bivalent vaccine doses, respectively. The FRPP partnership administered approximately two thirds of all bivalent COVID-19 vaccine doses in the United States and provided vaccine access for persons across a wide range of sociodemographic groups, demonstrating that this program could serve as a model to address vaccination services needs for routine vaccines and to provide health services in other public health emergencies.","PeriodicalId":18931,"journal":{"name":"Morbidity and Mortality Weekly Report","volume":"9 7","pages":"286 - 290"},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140745594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Erratum: Vol. 71, No. 19 勘误：第 71 卷第 19 期

Morbidity and Mortality Weekly Report Pub Date : 2024-04-04 DOI: 10.15585/mmwr.mm7313a4

引用次数: 0

Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 美国成人使用脊髓灰质炎灭活疫苗的情况：免疫实践咨询委员会的最新建议 - 美国，2023 年

Morbidity and Mortality Weekly Report Pub Date : 2023-12-08 DOI: 10.15585/mmwr.mm7249a3

Sarah Kidd, Thomas A. Clark, J. Routh, Sybil Cineas, Lynn Bahta, Oliver Brooks

引用次数: 0

Large Community Outbreak of Legionnaires Disease Potentially Associated with a Cooling Tower — Napa County, California, 2022 2022 年加利福尼亚州纳帕县爆发可能与冷却塔有关的大规模退伍军人病症社区疫情

Morbidity and Mortality Weekly Report Pub Date : 2023-12-08 DOI: 10.15585/mmwr.mm7249a1

Nárjara V. Grossmann, Crystal Milne, Melinda R. Martinez, Karen Relucio, Banafsheh Sadeghi, Erica N. Wiley, Samuel N. Holland, Sarah Rutschmann, D. Vugia, Akiko Kimura, Chad Crain, Farhima Akter, Rituparna Mukhopadhyay, John Crandall, Meghann Shorrock, Jessica C. Smith, Namrata Prasad, Rebecca Kahn, Albert E. Barskey, Sooji Lee, Melisa J. Willby, N. Kozak-Muiznieks, Claressa E. Lucas, Kelley C. Henderson, Jennafer A. P. Hamlin, Eungi Yang, Nakia S Clemmons, Troy Ritter, Jennifer Henn

引用次数: 0

Progress in Immunization Safety Monitoring — Worldwide, 2020–2022 2020-2022 年全球免疫安全监测进展情况

Morbidity and Mortality Weekly Report Pub Date : 2023-12-08 DOI: 10.15585/mmwr.mm7249a2

Erin F. Blau, M. Balakrishnan, Helena Sköld, Ravi Shankar Santhana Gopala Krishnan, Pinelopi Lundquist, Shanthi Pal, Jane F. Gidudu

引用次数: 0

Erratum: Vol. 72, No. 42 勘误：第 72 卷第 42 期

Morbidity and Mortality Weekly Report Pub Date : 2023-12-08 DOI: 10.15585/mmwr.mm7249a6

引用次数: 0

Vital Signs: Missed Opportunities for Preventing Congenital Syphilis — United States, 2022 生命体征:错失预防先天性梅毒的机会——美国，2022年

Morbidity and Mortality Weekly Report Pub Date : 2023-11-07 DOI: 10.15585/mmwr.mm7246e1

Robert McDonald, Kevin O'Callaghan, Elizabeth Torrone, Lindley Barbee, Jeremy Grey, David Jackson, Kate Woodworth, Emily Olsen, Jennifer Ludovic, Nikki Mayes, Sherry Chen, Rachel Wingard, Michelle Johnson Jones, Fanta Drame, Laura Bachmann, Raul Romaguera, Leandro Mena

引用次数: 0

QuickStats: Age-Adjusted Drug Overdose Death Rates* Involving Cocaine,† by Region§ — National Vital Statistics System, United States, 2021 QuickStats:涉及可卡因的年龄调整药物过量死亡率*，†按地区§-国家生命统计系统，美国，2021

Morbidity and Mortality Weekly Report Pub Date : 2023-10-13 DOI: 10.15585/mmwr.mm7241a4

引用次数: 0